TY  - JOUR 
AU  - Aparicio, Cristina
AU  - Acebal, Carlos
AU  - González-Vallinas, Margarita
PY  - 2023
SN  - 2162-3619
UR  - https://uvadoc.uva.es/handle/10324/81894
AB  - Chimeric antigen receptor (CAR)-T cell therapy is one of the most promising advances in cancer treatment. It is based on genetically modified T cells to express a CAR, which enables the recognition of the specific tumour antigen of interest. To date,...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Chimeric antigen receptor (CAR)-T cells
KW  - Cancer immunotherapy
KW  - “Off-the-shelf” adoptive T cell therapy
KW  - Allogeneic treatment
KW  - Advanced therapy medicinal products (ATMPs)
KW  - Genetic engineering
KW  - Graft-versus-host disease (GvHD)
KW  - Allorejection
KW  - Systematic review
TI  - Current approaches to develop “off-the-shelf” chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review
DO  - 10.1186/s40164-023-00435-w
ER  -